Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


(ˌæntɪˈɛstrədʒən; ˌæntɪˈiːstrədʒən)
the usual US spelling of antioestrogen
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014


(ˌæn tiˈɛs trə dʒən, ˌæn taɪ-)
a drug or other substance that inhibits, counteracts, or modifies the biological effects of estrogen.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.


n. antiestrógeno, sustancia que detiene o modifica la acción del estrógeno.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
Based on a clinical trial, the risk of her cancer returning is significantly less if we combine ovarian suppression and an antiestrogen hormonal therapy compared to antiestrogen hormonal therapy alone."
Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids.
All cases received pre-or postoperative chemotherapy [+ or -] antiestrogen therapy and, in locally advanced stages, palliative external radiotherapy.
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
Beyond surgery, multiple additional therapies have been tested, such as hormonal therapy with antiestrogen agents or gonadotropin agonists, sclerotherapy with tetracycline, potassium-titanyl-phosphate laser, and hyperthermic intraperitoneal chemotherapy (HIPEC) [2, 6, 7, 34].
Hess, "Infertility and testicular atrophy in the antiestrogen treated adult male rat," Biology of Reproduction, vol.
Shiu, "C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells," International Journal of Cancer, vol.
Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 1978; 103: 1742-51.
Given her critical illness and patient's desire for a less aggressive palliative approach, the patient elected for antiestrogen therapy with Fulvestrant over a trial of single-agent chemotherapy.
The product is a prescription medicine used to treat hormone receptor-positive metastatic breast cancer in women who have gone through menopause whose disease has spread following treatment with antiestrogen medicine.
Being female is also reported as a risk factor, and there may be a link between antiestrogen therapy and ABRT-ONJ (Vaszilko et al., 2014).